In an attempt to separate the neuroprotective effects of IL-1α from its neuroreparative effects, in these experiments we delayed IL-1α administration until PSD3, a time point at which the ischemic infarct is maximally evolved in our stroke model [22]. This evidence concerns the gene PSD3 and stroke disorder.